Decatur Capital Management’s Allergan plc AGN Stock Holding History

Decatur Capital Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-3,908	Closed	-$900K	–	122
2016 Q3	$900K	Sell	3,908 -3,747	-49%	-$916K	0.11%	89
2016 Q2	$1.77M	Sell	7,655 -2,315	-23%	-$534K	0.24%	74
2016 Q1	$2.67M	Buy	+9,970	New	+$2.85M	0.35%	65
2014 Q3	–	Sell	-51,100	Closed	-$11.4M	–	106
2014 Q2	$11.4M	Sell	51,100 -500	-1%	-$104K	2.15%	7
2014 Q1	$10.6M	Sell	51,600 -24,350	-32%	-$4.82M	2.02%	9
2013 Q4	$12.8M	Sell	75,950 -3,100	-4%	-$485K	2.46%	2
2013 Q3	$11.4M	Buy	79,050 +16,900	+27%	+$2.25M	2.4%	2
2013 Q2	$7.84M	Buy	+62,150	New	+$7.04M	2.72%	5

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Decatur Capital Management's AGN Position: Q4 2016 in Review

Decatur Capital Management sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 3,908 shares — an estimated $900K sold.

Decatur Capital Management first reported a position in AGN in Q2 2013 and held it in 8 quarters. The position peaked at $12.8M in Q4 2013. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

Decatur Capital Management reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
Decatur Capital Management sold 3,908 Allergan plc shares in Q4 2016, an estimated $900K.
Decatur Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 8 quarters.
Decatur Capital Management's Allergan plc position peaked at $12.8M in Q4 2013.
1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Decatur Capital Management's 13F filing for Q4 2016, filed 6 Feb 2017.